Dermatology · Phase 3 · Retention
Atopic Dermatitis Trial Retention: WCR Phase 3 Case
A Phase 3 atopic dermatitis study brought diary support, caregiver communication, and flexible appointment planning into participant follow-through.
Study experience and results: Wellness Clinical Research. Perspective by Wellness Global Research.
WCR-reported study results
Adolescent participation changes the practical plan
WCR reports that adolescents aged 12 to 17 accounted for 30% of randomized participants. Diary completion, family communication, school schedules, and caregiver availability therefore formed part of the study’s operational needs, alongside the requirements for adult participants.
Support continued beyond enrollment
The team describes diary follow-up, caregiver education, appointment flexibility, and transportation assistance. WCR reports reaching the enrollment goal in one month and a 100% participant completion result. The case does not disclose the total participant count or overall study duration.
Bring family logistics into feasibility
A site’s access to adolescents does not by itself describe its ability to support family participation. WGR helps teams discuss communication responsibilities, visit timing, diaries, and local support before activation. These details give sponsors a clearer view of the practical delivery model behind a pediatric or mixed-age forecast.
Apply the questions to your protocol
Connect the experience
to the study ahead.
Discuss investigator fit, patient access, study resources, and the support model with WGR’s central team.
Discuss your studyReview sponsor capabilitiesOriginal source
Atopic Dermatitis Trial Retention: WCR Phase 3 Case at Wellness Clinical ResearchWCR is WGR’s sister company. These are WCR’s reported study outcomes, presented here with original WGR commentary.